TABLE 1.
Transporters for UDP-sugars and sulfate, biosynthetic enzymes for PAPS and UDP-GlcA, and related proteins. Among the several transporters and biosynthetic enzymes involved in PAPS and UDP-sugars, GAG biosynthesis-related genes are listed here.
Transporters and enzymes | Coding genes | mRNA accession no | Phenotypes of KO or mutant mouse | Human genetic disorders | MIM number | Refs. For knockout mouse |
---|---|---|---|---|---|---|
UDP-glucose dehydrogenase | Ugdh | NM_009466 | Defects in migration of mesoderm and endoderm, and disturbance of FGF signaling | Developmental and epileptic encephalopathy 84 | 603370 | García-García and Anderson, (2003) |
618792 | ||||||
PAPS synthase 2 | Papss2 | NM_001201470 | A dome-shaped skull, reductions in limb size and axial skeletons, and disturbance of Indian hedgehog signaling | Brachyolmia 4 with mild epiphyseal and metaphyseal changes; Spondyloepimetaphyseal dysplasia Pakistani type (PAPSS2 type); Hyperandrogenism | 612847 | Orkin et al. (1976), Schwartz et al. (1978), Sugahara and Schwartz (1979), Sugahara and Schwartz (1982a), Sugahara and Schwartz (1982b), Pennypacker et al. (1981), Cortes et al. (2009) |
NM_001360403 | ||||||
NM_011864 | ||||||
603005 | ||||||
Diastrophic dysplasia sulfate transporter (Solute carrier family 26 member A2) | Slc26a2 | NM_007885 | Growth retardation, joint contractures, and skeletal dysplasia including irregular size of chondrocytes, delay in the formation of the secondary osscification center, osteoporosis of long bone, severe thoracic kyphosis, bite overclosure, and hip dysplasia with pelvic deformity | Achondrogenesis type IB; Atelosteogenesis type II; De la Chapelle dysplasia; Diastrophic dysplasia; Diastrophic dysplasia, broad bone-platyspondylic variant; Epiphyseal dysplasia multiple 4 | 600972 | Forlino et al. (2005) |
256050 | ||||||
222600 | ||||||
226900 | ||||||
606718 | ||||||
UDP-GlcA/UDP-GalNAc dual transporter (Solute carrier family 35 member D1) | Slc35d1 | NM_001356276 | A lethal form of skeletal dysplasia including severe shortening of limbs, a decreased proliferating zone with round chondrocytes in the face, and scarce matrices | Schneckenbecken dysplasia | 610804 | Hiraoka et al. (2007) |
NM_177732 | 269250 | |||||
UDP 5′-diphosphatase | Cant1 | NM_001025617 | A moderate kyphosis, decrease in both length and width of tibiae, femurs, and ilium, delta phalanx, and a defect in endochondral ossification | Desbuquois dysplasia 1 | 617719 | Paganini et al. (2019), Kodama et al. (2020) |
NM_001025618 | Epiphyseal dysplasia multiple 7 | 251450 | ||||
NM_001267591 | Pseudodiastrophic dysplasia | 613165 | ||||
NM_001267592 | 264180 | |||||
NM_029502 | ||||||
3′-phosphoadenosine 5′-phosphate 3′-phosphatase | Bpnt2/Impad1 | NM_177730 | Either neonatal or embryonic lethality, reductions of limb length, shortening of the snout and lower limbs, and reduced sternal length | Chondrodysplasia with joint dislocations GRAPP type | 614078 | Frederick et al. (2008) |
614010 | ||||||
Golgin, Rab6-interacting protein | Gorab | NM_001313738 | Neonatal lethal. Abnormal collagen fibrils, thinned and porous cortical bone, and spontaneous fractures | Geroderma osteodysplasticum | 607983 | Chan et al. (2018) |
NM_178883 | 231070 |
Cant1, calcium activated nucleotidase 1; Bpnt2, 3′(2′), 5′-bisphosphate nucleotidase 2; Impad1, inositol monophosphatase domain-containing protein 1; GRAPP, Golgi-resident phosphoadenosine phosphate phosphatase; MIM, mendelian inheritance in man.